Back to Search
SUDHAKAR PAPINENI, M.D.
M.D.
Internal Medicine Physician
NPI: 1831143064Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
M1999(TX)
Research & Publications (19)
Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met.
PMID 19406933·Carcinogenesis·2009
7-preclinical
Methyl 2-cyano-3,11-dioxo-18 beta-olean-1,12-dien-30-oate is a peroxisome proliferator-activated receptor-gamma agonist that induces receptor-independent apoptosis in LNCaP prostate cancer cells.
PMID 17989348·Mol Pharmacol·2008
4-observational
p21 expression is induced by activation of nuclear nerve growth factor-induced Balpha (Nur77) in pancreatic cancer cells.
PMID 19584258·Mol Cancer Res·2009
8-other
Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells.
PMID 19582879·Int J Cancer·2009
7-preclinical
Induction of apoptosis and nonsteroidal anti-inflammatory drug-activated gene 1 in pancreatic cancer cells by a glycyrrhetinic acid derivative.
PMID 19125423·Mol Carcinog·2009
7-preclinical
1,1-Bis(3'-indolyl)-1-(p-chlorophenyl)methane activates the orphan nuclear receptor Nurr1 and inhibits bladder cancer growth.
PMID 19074857·Mol Cancer Ther·2008
7-preclinical
5,5'-Dibromo-bis(3'-indolyl)methane induces Kruppel-like factor 4 and p21 in colon cancer cells.
PMID 18645021·Mol Cancer Ther·2008
7-preclinical
Curcumin decreases specificity protein expression in bladder cancer cells.
PMID 18593936·Cancer Res·2008
7-preclinical
Cancer chemotherapy with indole-3-carbinol, bis(3'-indolyl)methane and synthetic analogs.
PMID 18501502·Cancer Lett·2008
6-review
1,1-bis(3'-indolyl)-1-(p-methoxyphenyl)methane activates Nur77-independent proapoptotic responses in colon cancer cells.
PMID 17957723·Mol Carcinog·2008
8-other
2-cyano-lup-1-en-3-oxo-20-oic acid, a cyano derivative of betulinic acid, activates peroxisome proliferator-activated receptor gamma in colon and pancreatic cancer cells.
PMID 17724373·Carcinogenesis·2007
7-preclinical
Structure-dependent activity of glycyrrhetinic acid derivatives as peroxisome proliferator-activated receptor {gamma} agonists in colon cancer cells.
PMID 17513608·Mol Cancer Ther·2007
8-other
Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors.
PMID 17363604·Cancer Res·2007
7-preclinical
1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes inhibit growth, induce apoptosis, and decrease the androgen receptor in LNCaP prostate cancer cells through peroxisome proliferator-activated receptor gamma-independent pathways.
PMID 17093136·Mol Pharmacol·2007
8-other
The role of xenoestrogenic compounds in the development of breast cancer.
PMID 16822555·Trends Pharmacol Sci·2006
6-review
1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through PPARgamma-dependent and PPARgamma-independent pathways.
PMID 16731770·Mol Cancer Ther·2006
7-preclinical
1,1-Bis(3'-indolyl)-1-(p-substitutedphenyl)methanes are peroxisome proliferator-activated receptor gamma agonists but decrease HCT-116 colon cancer cell survival through receptor-independent activation of early growth response-1 and nonsteroidal anti-inflammatory drug-activated gene-1.
PMID 16155208·Mol Pharmacol·2005
8-other
Activation of Nur77 by selected 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes induces apoptosis through nuclear pathways.
PMID 15871945·J Biol Chem·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3315 S ALAMEDA ST
CORPUS CHRISTI, TX 78411 - Phone
- (361) 857-1400
Quick Facts
- NPI
- 1831143064
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 19
Are you this provider?
Claim Your Profile